Correlation Between Cullinan Oncology and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Cullinan Oncology and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Apellis Pharmaceuticals.
Diversification Opportunities for Cullinan Oncology and Apellis Pharmaceuticals
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cullinan and Apellis is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Apellis Pharmaceuticals
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the Apellis Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Cullinan Oncology LLC is 1.33 times less risky than Apellis Pharmaceuticals. The stock trades about -0.12 of its potential returns per unit of risk. The Apellis Pharmaceuticals is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 3,191 in Apellis Pharmaceuticals on November 1, 2024 and sell it today you would lose (244.00) from holding Apellis Pharmaceuticals or give up 7.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.0% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Apellis Pharmaceuticals |
Cullinan Oncology and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Apellis Pharmaceuticals
The main advantage of trading using opposite Cullinan Oncology and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |